Skip to main content

Resurrect Bio closes $10.3M Series A for AI-led crop immunity

UK ag-biotech Resurrect Bio, a spinout of The Sainsbury Laboratory in Norwich, has closed an oversubscribed $10.3 million Series A.

Resurrect Bio closes $10.3M Series A for AI-led crop immunity

The round is up from an $8.1 million first close in February and was led by Corteva through its Catalyst platform, with Calculus Capital, Pymwymic, UKI2S, SynBioVen and AgFunder participating. Total funding now stands at about $12.4 million.

The company uses an AI-driven platform to restore crops' native disease-resistance genes, reducing chemical dependence, and recently signed a joint development agreement with Corteva on disease resistance in corn.

Pairing a top-tier strategic lead (Corteva) with European deep-tech and impact funds is exactly the kind of syndicate construction European ag-biotech founders should be aiming for in 2026.

References: AgTechNavigator (https://www.agtechnavigator.com/Article/2026/05/13/resurrect-bio-closes-103m-series-a-as-investors-back-ai-led-crop-immunity/); EU-Startups (https://www.eu-startups.com/2026/05/uk-agribiotech-startup-resurrect-bio-closes-e8-8-million-series-a-to-develop-disease-resistant-crops/); Pulse 2.0 (https://pulse2.com/resurrect-bio-10-3-million-oversubscribed-series-a-raised-to-accelerate-crop-disease-resistance/).

Source: AgTechNavigator